DOI: 10.7504/nk2015010111
Mechanism-guided treatment:decitibine in the treatment of myelodysplastic syndromes
HE Guang-sheng
Keywords：myelodysplastic syndromedecitibinehematopoiesisimmunoregulationP53resistance
Publication Date：2015-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)